Welcome to our dedicated page for Nova SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nova Ltd. filings document its foreign private issuer reporting for a semiconductor metrology and process control company. Form 6-K current reports incorporate press releases on financial results, scheduled earnings releases, investor conference participation, product adoption for Nova Metrion®, and other operating updates. The Form 20-F annual report includes audited consolidated financial statements and establishes the company's reporting framework under Form 20-F rather than Form 40-F.
The filing record also identifies Nova's Nasdaq ticker NVMI and TASE trading status. Current reports preserve formal notices for annual-report availability, scheduled conference calls and public communications made under Exchange Act Rule 13a-16 or 15d-16.
NOVA LTD. director Eitan Oppenhaim reported an open-market sale of 1,504 ordinary shares on May 26, 2026 at an average price of $519.48 per share. Following the transaction, he directly holds 6,668 ordinary shares.
Footnotes state these holdings include 646 ordinary shares and several blocks of restricted share units (RSUs): 1,504 RSUs vesting annually through 2027, 1,932 RSUs vesting annually through 2028, and 2,586 RSUs scheduled to vest on June 18, 2026, each RSU convertible into one ordinary share upon vesting and settlement.
The filing is a Rule 144 resale notice for securities listed on Nasdaq, showing numeric disclosures and proposed restricted stock unit entries. The excerpt lists 2794, a monetary figure of $1,406,751.06, and 31,780,111 with an associated date of 05/26/2026. It also records two grant lines of 6,014 RSUs (05/18/2023) and 2,578 RSUs (06/20/2024).
NOVA LTD. director Sagiv Sarit reported an open-market sale of 426 Ordinary Shares on May 18, 2026 at an average price of $514.49 per share. After the sale, Sarit directly holds 2,437 Ordinary Shares.
In addition to those shares, Sarit has multiple outstanding restricted share unit (RSU) awards. These include 454 RSUs vesting in equal annual installments through 2026, 426 RSUs vesting through 2027, 546 RSUs vesting through 2028, and 827 RSUs that are scheduled to fully vest on June 18, 2026, each RSU representing one Ordinary Share upon vesting and settlement.
Nova Ltd. director Zehava Simon reported an open-market sale of 426 ordinary shares at $514.49 per share on May 18, 2026. After this transaction, Simon holds 2,437 shares directly, including ordinary shares and several RSU awards scheduled to vest through 2028.
NOVA LTD. director Yaniv Garty completed an open-market sale of 426 ordinary shares at $514.49 per share. After this sale, he directly holds 2,038 ordinary shares. His position also includes multiple restricted share unit awards that vest annually through 2028 and one grant vesting on June 18, 2026.
Company submitted a Form 144 notice listing proposed sales of ordinary shares arising from Restricted Stock Units. The excerpt lists three RSU grant dates and quantities: 1,704 RSUs (05/18/2023), 730 RSUs (06/20/2024) and 1,814 RSUs (06/23/2022). The filing names Oppenheimer & Co. Inc. as a broker with an address at 85 Broad St., New York.
Nova Ltd. filed a Form 6-K to share a press release announcing that its management team will take part in several upcoming investor conferences and events in May and June 2026. These appearances include virtual one-on-one meetings, an in-person investor bus tour, and multiple fireside chats in California.
Chief Executive Officer Gaby Waisman and Chief Financial Officer Guy Kizner will host sessions in Fremont and San Francisco, with live webcasts of the Evercore and Bank of America fireside chats accessible through Nova’s investor relations website. The release also reiterates Nova’s role as a provider of metrology and process control solutions for semiconductor manufacturing and includes standard forward-looking statement language outlining business and macro risks.
NVMI submitted a Form 144 reporting proposed sales of Ordinary shares through Oppenheimer & Co. Inc.. The filing lists 1,246 shares with an aggregate value of $634,400.90, and a reported outstanding share figure of 31,780,111 as of 05/18/2026. The filing also itemizes previously issued Restricted Stock Units granted on 06/23/2022 (1,814 RSUs), 05/18/2023 (1,704 RSUs) and 06/20/2024 (730 RSUs).
NVMI filing reports a resale under Rule 144 by an affiliate. The filing records a sale of 55 ordinary shares on 04/02/2026 with aggregate consideration of $23,375.00. The filing also lists 1,704 Restricted Stock Units dated 05/18/2023 associated with the issuer.
Nova Ltd. has called its annual shareholder meeting for June 18, 2026 in Rehovot, Israel. Holders of ordinary shares at the close of business on May 19, 2026 may vote, with 31,806,161 shares outstanding as of May 12, 2026.
Shareholders are asked to re-elect six current directors and elect Rami Hadar, keeping a seven-member board where six directors are Nasdaq‑independent. A second proposal seeks approval of amended employment terms for President and CEO Gabriel Waisman and aligned changes to the executive compensation policy, including a higher base salary and new performance share units tied to relative total shareholder return plus updated bonus weightings, while maintaining an overall cap of 10% of non‑GAAP operating profit for annual executive bonuses.
The third proposal would re‑appoint Kost Forer Gabbay & Kasierer, a member of EY Global, as independent auditors until the next annual meeting. Proposal 2 is subject to a special voting test that excludes controlling and other Interested Shareholders from the approving majority tally, and the vote on CEO pay is binding under Israeli law, with only limited circumstances permitting a board override.